Disclosure of Conflicts of Interest
CE Reporting: You will receive an email with instructions on accessing the portal following the conclusion of the Virtual Experience.
2021 Fall IDN Summit
This activity is jointly provided by
Faculty/Planner/Reviewer Disclosure of Conflicts of Interest
Disclosure of Conflicts of Interest
AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is t producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity.
AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.
The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:
Name of Faculty or Presenter |
Reported Financial Relationship |
Chris Box |
Nothing to disclose |
Martina Brooks |
Nothing to disclose |
Mark Campbell |
Nothing to disclose |
Jimmy Y. Chung, MD, MBA, FACS, FABQAURP, CMRP |
Nothing to disclose |
Arash T. Dabestani PharmD, MHA, FASHP, FABC |
Consultant: Omnicell |
Marisa Farabaugh |
Nothing to disclose |
Nick Gaich |
Nothing to disclose |
Abel Haile |
Nothing to disclose |
Tom Harvieux |
Nothing to disclose |
Bonnie Kirschenbaum, BScPharm, MS, FASHP, FCSHP |
Nothing to disclose |
Gina Lohr |
Nothing to disclose |
Deepak Manmohan Goyal MD, MBBS, CPE, CHCQM-PHYADV |
Nothing to disclose |
Steven Schnelle |
Nothing to disclose |
Joanne Schlosser |
Nothing to disclose |
Rodney Whitlock, PhD |
Nothing to disclose |
Kenny Yu, Pharm.D., MBA, ACE |
Nothing to disclose |
The planners/managers/reviewers reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:
Name of Planner/Manager |
Reported Financial Relationship |
Brent Petty, CMRP |
Nothing to disclose |
Ellie Wnek |
Nothing to disclose |
Robert Chafin |
Nothing to disclose |
Dee Morgillo, MEd., MT(ASCP), CHCP |
Nothing to disclose |
Holly M. Hampe, D.Sc., RN, MHA, MRM |
Nothing to disclose |